In vitro susceptibility tests provide information on the intrinsic response of Plasmodium vivax to antimalarials, free from confounding factors such as host immunity or relapse. This study examined the utility of radioisotope and PicoGreen assays as alternatives to the traditional microscopic examination for assessing response of P. vivax to antimalarial drugs. There was no significant difference in the mean chloroquine IC50 of P. vivax (n = 40) as determined by the microscopic (33.4 ng/ml), isotopic (33.6 ng/ml), and PicoGreen (39.1 ng/ml) assays, respectively (F = 0.239, df = 2, 51, and p = 0.788). However measurement of IC50s by the microscopic method was slightly more successful in producing valid assays (57%), compared to the isotopic ...
BACKGROUND The prompt diagnosis of plasmodial species for effective treatment prevents worsening o...
Abstract. Chloroquine-resistant Plasmodium vivax malaria is emerging in Oceania, Asia, and Latin Ame...
Abstract Background While intensive Plasmodium falciparum multidrug resistance surveillance continue...
In vitro susceptibility tests provide information on the intrinsic response of Plasmodium vivax to a...
The aim of this study was to develop a simple, field-practical, and effective in vitro method for de...
Ex vivo antimalarial sensitivity testing in humanmalaria parasites has largely depended on microscop...
BACKGROUND: Plasmodium vivax is a major cause of malaria and is still primarily treated with chloroq...
The emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent ...
The emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent ...
In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax (n = 216) and P. falciparum...
From March 1996 to August 1997, a study was carried out in a malaria endemic area of the Brazilian A...
Ex vivo antimalarial sensitivity testing in human malaria parasites has largely depended on microsco...
The emergence and spread of multidrug-resistant Plasmodium falciparum and Plasmodium vivax highlight...
The usefulness of an isotopic in vitro assay in the field was evaluated by comparing its results wit...
Plasmodium vivax (Pv) is the second most important human malaria parasite. Recent data indicate that...
BACKGROUND The prompt diagnosis of plasmodial species for effective treatment prevents worsening o...
Abstract. Chloroquine-resistant Plasmodium vivax malaria is emerging in Oceania, Asia, and Latin Ame...
Abstract Background While intensive Plasmodium falciparum multidrug resistance surveillance continue...
In vitro susceptibility tests provide information on the intrinsic response of Plasmodium vivax to a...
The aim of this study was to develop a simple, field-practical, and effective in vitro method for de...
Ex vivo antimalarial sensitivity testing in humanmalaria parasites has largely depended on microscop...
BACKGROUND: Plasmodium vivax is a major cause of malaria and is still primarily treated with chloroq...
The emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent ...
The emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent ...
In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax (n = 216) and P. falciparum...
From March 1996 to August 1997, a study was carried out in a malaria endemic area of the Brazilian A...
Ex vivo antimalarial sensitivity testing in human malaria parasites has largely depended on microsco...
The emergence and spread of multidrug-resistant Plasmodium falciparum and Plasmodium vivax highlight...
The usefulness of an isotopic in vitro assay in the field was evaluated by comparing its results wit...
Plasmodium vivax (Pv) is the second most important human malaria parasite. Recent data indicate that...
BACKGROUND The prompt diagnosis of plasmodial species for effective treatment prevents worsening o...
Abstract. Chloroquine-resistant Plasmodium vivax malaria is emerging in Oceania, Asia, and Latin Ame...
Abstract Background While intensive Plasmodium falciparum multidrug resistance surveillance continue...